Emergency Department Management of Patients With Renal Infarction

July 17, 2024 updated by: Saglik Bilimleri Universitesi
The aim of this study is to investigate laboratory parameters from medical records of patients diagnosed with renal infarction in our emergency clinic to establish early diagnostic indicators. Additionally, we will evaluate imaging methods such as CT or CT angiography and identify mortality-morbidity markers to contribute to the literature.

Study Overview

Detailed Description

It is planned to include 80 patients who presented to the hospital emergency department and were diagnosed with renal infarction between January 1, 2014, and June 1, 2023, in the study.

he data of patients diagnosed with renal infarction will be retrospectively collected from the hospital database and recorded in a data collection form. This includes information such as CBC (complete blood count), neutrophils, lymphocytes, platelets, lactate, anion gap, pH, bicarbonate, creatinine, urea, AST, ALT, fibrinogen, D-dimer, LDH, CRP, CT scan, and CT angiography results. Patients' demographic characteristics, physical examination findings, imaging, and laboratory results will be evaluated using patient records and the hospital registry system.

Our aim is to identify early morbidity and mortality indicators in cases of renal infarction where diagnosis is often delayed or missed, contributing to the survival of patients. We believe that the findings from our statistical analysis can guide routine practice, especially in the management of patients presenting to the emergency department with complaints of abdominal and/or flank pain

Study Type

Observational

Enrollment (Actual)

80

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Altindag
      • Ankara, Altindag, Turkey, 06110
        • Diskapi Teaching and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

N/A

Sampling Method

Probability Sample

Study Population

patients administered to emergency department and diagnosed with renal infarction will be retrospectively determined from hospital data system.

Description

Inclusion criteria:

Adult patients aged 18 years and older Cases diagnosed with renal infarction presenting to the Emergency Department of Dışkapı Yıldırım Beyazıt Training and Research Hospital

Exclusion criteria:

Patients without imaging methods Patients with incomplete laboratory and file follow-ups Patients previously diagnosed with renal infarction and currently under treatment Patients diagnosed with other clinical conditions such as pyelonephritis, lower urinary tract infections, nephrolithiasis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Renal Infarction
Patients diagnosed with renal infarction using data obtained from the hospital system have been reviewed and evaluated. Laboratory, clinical and imaging data ahve been registered and statistical analyses have been conducted

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Renal Infarction
Time Frame: 9 years
patients diagnosed with renal infarction
9 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: gulsen akcay, ass. prof., ass. prof. of organization

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 15, 2024

Primary Completion (Actual)

May 15, 2024

Study Completion (Actual)

May 15, 2024

Study Registration Dates

First Submitted

July 17, 2024

First Submitted That Met QC Criteria

July 17, 2024

First Posted (Actual)

July 23, 2024

Study Record Updates

Last Update Posted (Actual)

July 23, 2024

Last Update Submitted That Met QC Criteria

July 17, 2024

Last Verified

July 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • RENAL INFARCTION

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Renal Infarct

Subscribe